CSN2_STRTR
ID CSN2_STRTR Reviewed; 219 AA.
AC G3ECR4;
DT 13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT 16-NOV-2011, sequence version 1.
DT 03-AUG-2022, entry version 25.
DE RecName: Full=CRISPR-associated protein Csn2;
GN Name=csn2;
OS Streptococcus thermophilus.
OC Bacteria; Firmicutes; Bacilli; Lactobacillales; Streptococcaceae;
OC Streptococcus.
OX NCBI_TaxID=1308;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION IN PLASMID RESISTANCE,
RP EXPRESSION OF CRISPR3/CAS IN E.COLI, AND DISRUPTION PHENOTYPE.
RC STRAIN=DGCC7710;
RX PubMed=21813460; DOI=10.1093/nar/gkr606;
RA Sapranauskas R., Gasiunas G., Fremaux C., Barrangou R., Horvath P.,
RA Siksnys V.;
RT "The Streptococcus thermophilus CRISPR/Cas system provides immunity in
RT Escherichia coli.";
RL Nucleic Acids Res. 39:9275-9282(2011).
CC -!- FUNCTION: CRISPR (clustered regularly interspaced short palindromic
CC repeat) is an adaptive immune system that provides protection against
CC mobile genetic elements (viruses, transposable elements and conjugative
CC plasmids). CRISPR clusters contain spacers, sequences complementary to
CC antecedent mobile elements, and target invading nucleic acids. CRISPR
CC clusters are transcribed and processed into CRISPR RNA (crRNA)
CC (Probable). Binds dsDNA (By similarity). When the CRISPR3/cas system
CC consisting of cas9-cas1-cas2-csn2-CRISPR3 or just cas9-CRISPR3 is
CC expressed in E.coli it prevents plasmids homologous to spacers 1 or 2
CC from transforming. {ECO:0000250, ECO:0000269|PubMed:21813460,
CC ECO:0000305}.
CC -!- COFACTOR:
CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC -!- DISRUPTION PHENOTYPE: Plasmid transformation is still inhibited.
CC {ECO:0000269|PubMed:21813460}.
CC -!- SIMILARITY: Belongs to the CRISPR-associated Csn2 protein family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; HQ712120; AEM62890.1; -; Genomic_DNA.
DR RefSeq; WP_014608593.1; NZ_WMLD01000001.1.
DR PDB; 6QXF; EM; 3.60 A; A/B/C/D/E/F/G/H=1-219.
DR PDB; 6QXT; EM; 8.90 A; A/B/C/D/E/F/G/H/a/b/c/d/e/f/g/h=1-219.
DR PDB; 6QY3; EM; 9.10 A; A/B/C/D/E/F/G/H/a/b/c/d/e/f/g/h=1-219.
DR PDBsum; 6QXF; -.
DR PDBsum; 6QXT; -.
DR PDBsum; 6QY3; -.
DR AlphaFoldDB; G3ECR4; -.
DR SMR; G3ECR4; -.
DR STRING; 322159.STER_1474; -.
DR eggNOG; ENOG502ZVZK; Bacteria.
DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR Gene3D; 3.40.50.11940; -; 2.
DR InterPro; IPR010146; CRISPR-assoc_prot_Csn2-typ.
DR InterPro; IPR038600; Csn2_sf.
DR Pfam; PF09711; Cas_Csn2; 1.
DR TIGRFAMs; TIGR01866; cas_Csn2; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Antiviral defense; Calcium; DNA-binding; Metal-binding.
FT CHAIN 1..219
FT /note="CRISPR-associated protein Csn2"
FT /id="PRO_0000417880"
FT BINDING 138
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /evidence="ECO:0000250"
FT BINDING 150
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /evidence="ECO:0000250"
SQ SEQUENCE 219 AA; 25513 MW; 6724B909085E7349 CRC64;
MKINFSLLDE PMEVNLGTVL VIEDVSVFAQ LVKEFYQYDE QSNLTIFDSK IRSIRSSELL
LITDILGYDI NTSQVLKLLH TDIVSQLNDK PEVRSEIDSL VSLITDIIMA ECIENELDIE
YDEITLLELI KALGVRIETK SCTVFEKIFE ILQIFKYLVK KRILVFVNSL SYFSKDEIYQ
ILEYTKLSQA DVLFLEPRQI EGIQQFILDK DYILMPYNN